Respiratory Tract Diseases  >>  toreforant (JNJ-38518168)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
toreforant (JNJ-38518168) / J&J
NCT01823016 / 2012-004920-39: A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma

Completed
2a
166
US, Canada, Europe, RoW
Placebo, JNJ-38518168
Janssen Research & Development, LLC
Asthma
07/15
07/15

Download Options